<?xml version="1.0" encoding="UTF-8"?>
<p id="p0385">However, there are some challenges in the collection of plasma from donor serum during the recovery period or after recovery, and confirming the proper level of neutralizing antibody titer. Some of these challenges are the availability of willing qualified donors, clinical conditions, eliminating host interactions, and the viral kinetics of SARS-CoV-2, that will need to be solved before convalescent plasma can become a generalized therapeutic option.</p>
